Technical Analysis for BCT - Briacell Therapeutics Corp.

Grade Last Price % Change Price Change
F 1.050 8.25% 0.080
BCT closed up 8.25 percent on Wednesday, July 24, 2024, on 1.21 times normal volume. The bears made the stock sink to a new 52-week low.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Inside Day Range Contraction 8.25%
Wide Bands Range Expansion 8.25%
Below Lower BB Weakness 8.25%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Briacell Therapeutics Corp. Description

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company. The Company is engaged in the research and development of cancer immunotherapy technology. The Company offers BriaVax, an immunotherapy vaccine. The Company is engaged in developing and advancing its BriaVax immunotherapy vaccine for patients with advanced breast cancer. The Company is also engaged in the research and development of its companion diagnostic product, BriaDx. The Company's BriaDx program is focused on analyzing samples obtained from patients previously treated with BriaVax along with co-analysis of previously manufactured vaccine lots. The Company's analysis methods include various technologies, including gene expression profiling by Illumina microarrays and human leukocyte antigen (HLA) typing by a high-resolution method. The Company is focused on understanding the mechanism of action (MoA) of BriaVax.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Medical Specialties Therapy Oncology Immunology Antigen Immunotherapy Cancer Immunotherapy Biotechnology Companies Breast Cancer Vaccine

Is BCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.29
52 Week Low 0.84
Average Volume 15,542
200-Day Moving Average 4.342
50-Day Moving Average 1.702
20-Day Moving Average 1.277
10-Day Moving Average 1.139
Average True Range 0.147
RSI (14) 35.90
ADX 37.86
+DI 15.119
-DI 38.353
Chandelier Exit (Long, 3 ATRs) 1.269
Chandelier Exit (Short, 3 ATRs) 1.281
Upper Bollinger Bands 1.614
Lower Bollinger Band 0.939
Percent B (%b) 0.16
BandWidth 52.882
MACD Line -0.212
MACD Signal Line -0.212
MACD Histogram -0.0009
Fundamentals Value
Market Cap 810.56 Thousand
Num Shares 772 Thousand
EPS -0.04
Price-to-Earnings (P/E) Ratio -27.63
Price-to-Sales 0.00
Price-to-Book 10.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.365
Resistance 3 (R3) 1.330 1.190 1.313
Resistance 2 (R2) 1.190 1.110 1.208 1.295
Resistance 1 (R1) 1.120 1.060 1.155 1.155 1.277
Pivot Point 0.980 0.980 0.998 0.998 0.980
Support 1 (S1) 0.910 0.900 0.945 0.945 0.823
Support 2 (S2) 0.770 0.850 0.788 0.805
Support 3 (S3) 0.700 0.770 0.788
Support 4 (S4) 0.735